Lumyai Wonglakorn
Khon Kaen University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lumyai Wonglakorn.
Journal of Antimicrobial Chemotherapy | 2012
Benchamas Rimrang; Aroonwadee Chanawong; Aroonlug Lulitanond; Chotechana Wilailuckana; Nicha Charoensri; Pipat Sribenjalux; Waewta Phumsrikaew; Lumyai Wonglakorn; Anusak Kerdsin; Ploenchan Chetchotisakd
OBJECTIVES To detect carbapenemases in clinical isolates of Enterobacteriaceae collected from patients in a university hospital in Thailand between October 2010 and August 2011. METHODS A total of 4818 Enterobacteriaceae isolates were screened for the presence of carbapenemases by ertapenem and imipenem disc diffusion tests. All positive screening isolates were subjected to modified Hodge test, phenylboronic acid- and EDTA-carbapenem combined disc tests and two multiplex PCRs of bla(IMP), bla(VIM), bla(SPM), bla(SIM) and bla(GIM), and of bla(KPC), bla(NDM) and bla(OXA-48). Carbapenemase-producing isolates were typed by PFGE and then characterized by antimicrobial susceptibility tests. Conjugation was performed using a broth culture mating method. RESULTS Two isolates each of Escherichia coli, Klebsiella pneumoniae and Citrobacter freundii produced NDM-1, whereas two other isolates of K. pneumoniae produced IMP-14a. DNA fingerprints revealed that the metallo-β-lactamase (MBL)-producing isolates were of different strains except for clonal strains of C. freundii. In vitro transfer of carbapenem resistance was successful for the eight MBL-producing isolates. All MBL producers were susceptible to colistin and tigecycline. The six NDM-producing isolates were recovered from the urine of three patients, who had no history of travel outside Thailand. Interestingly, one patient had chronic urinary tract infections caused by a K. pneumoniae strain and two strains of E. coli producing NDM-1. CONCLUSIONS Surveillance of carbapenemases, particularly NDM-1, in Enterobacteriaceae is urgently needed to control and prevent the spread of these resistance determinants in our country.
Journal of Medical Microbiology | 2015
Siwaporn Sinlapasorn; Aroonlug Lulitanond; Sunpetch Angkititrakul; Aroonwadee Chanawong; Chotechana Wilailuckana; Ratree Tavichakorntrakool; Kanoksak Chindawong; Charinya Seelaget; Mana Krasaesom; Sarawut Chartchai; Lumyai Wonglakorn; Pipat Sribenjalux
Livestock-associated meticillin-resistant Staphylococcus aureus, clonal complex (CC) 398, has been reported in Europe, whereas CC9 MRSA has mostly been found in Asia. Therefore, we aimed to detect MRSA on pig farms in north-eastern Thailand. A total of 257 nasal swabs (159 samples from pigs and 98 from pig-farm workers) were collected from three pig farms in north-eastern Thailand from 2010 to 2011. MRSA isolates were confirmed for femA and mecA genes by PCR. The MICs of eight antimicrobials, namely vancomycin (VA), cefazolin (CZ), ofloxacin (OF), tetracycline (TET), erythromycin (ER), oxacillin (OX), cefoxitin (FOX) and gentamicin (GN), were tested by agar dilution method. The virulence genes for Panton-Valentine leukocidin toxin (lukSF-PV), toxic shock syndrome toxin-1 (tst) and α-haemolysin (hla) were detected by PCR. Strain typing was performed by staphylococcal cassette chromosome (SCC) mec, agr, spa and multilocus sequence typing. Four MRSA were isolated: three from workers and one from a pig. All the MRSA isolates were resistant to OX, GN, ER, TET and CZ, and they all carried hla only. Two MRSA from humans carried SCCmec II-sequence type (ST)764-agrII, whereas the two remaining MRSA (one each from a human and a pig) contained SCCmec IX-ST9-agrII. Interestingly, meticillin-resistant coagulase-negative Staphylococcus isolates carrying SCCmec IX were also obtained from five workers and three pigs. This study suggests that the SCCmec IX element is distributed among the Staphylococcus found in pigs and pig-farm workers, and pigs may be a reservoir for MRSA in the community.
Japanese Journal of Infectious Diseases | 2017
Sawitree Nuramrum; Aroonwadee Chanawong; Kamonwan Lunha; Aroonlug Lulitanond; Arunnee Sangka; Chotechana Wilailuckana; Sunpetch Angkititrakul; Nicha Charoensri; Lumyai Wonglakorn; Prajuab Chaimanee; Ploenchan Chetchotisakd
Twelve nonreplicate carbapenemase-negative ertapenem (ETP)-nonsusceptible (CNENS) Escherichia coli isolates obtained at a Thai university hospital between 2010 and 2014 were characterized and compared with 2 carbapenemase-producing E. coli isolates from the same hospital. Eight unique pulsed-field gel electrophoresis patterns were obtained. All the isolates produced CTX-M-15 β-lactamase and 2 either coexpressed CMY-2 cephalosporinase or showed increased efflux pump activity. Amino acid sequence analysis revealed that an OmpF defect (in 7 isolates) due to mutations generating truncated proteins or an IS1 insertion was more prevalent than a defect in OmpC was (no truncated proteins detected). Seven out of 10 isolates possessing OmpC variants with any OmpF defect were weakly ETP-resistant (minimum inhibitory concentrations [MICs] of 1-4 μg/mL) and imipenem (IPM)- and meropenem (MEM)-susceptible (MICs 0.125-0.5 μg/mL). Two isolates with ompC PCR-negative results and an OmpF defect showed higher carbapenem MICs (8-32, 1-8, and 1-4 μg/mL for ETP, IPM, and MEM, respectively) with the highest MICs associated with the additional efflux pump activity. Both carbapenemase producers possessing CTX-M-15 and a porin background identical to that in the CNENS isolates showed ETP, IPM, and MEM MICs of 128-256, 8, and 2-32 μg/mL, respectively. These findings suggest that a porin defect combined with CTX-M-15 production is the major mechanism of low carbapenem susceptibility among our CNENS isolates, which have potential to become strongly carbapenem-resistant because of additional carbapenemase or efflux pump activities.
Diagnostic Microbiology and Infectious Disease | 2016
Kamonwan Lunha; Aroonwadee Chanawong; Aroonlug Lulitanond; Chotechana Wilailuckana; Nicha Charoensri; Lumyai Wonglakorn; Pimjai Saenjamla; Prajuab Chaimanee; Sunpetch Angkititrakul; Ploenchan Chetchotisakd
Mycopathologia | 2013
Yordhathai Thongsri; Lumyai Wonglakorn; Angkana Chaiprasert; Lucie Svobodova; P. Hamal; Maitree Pakarasang; Chularut Prariyachatigul
World Journal of Microbiology & Biotechnology | 2016
Arpasiri Srisrattakarn; Aroonlug Lulitanond; Chotechana Wilailuckana; Nicha Charoensri; Lumyai Wonglakorn; Sirikan Piyapatthanakul; Ampai Supajeen; Aroonwadee Chanawong
World Journal of Microbiology & Biotechnology | 2017
Arpasiri Srisrattakarn; Aroonlug Lulitanond; Chotechana Wilailuckana; Nicha Charoensri; Lumyai Wonglakorn; Pimjai Saenjamla; Prajuab Chaimanee; Jureerut Daduang; Aroonwadee Chanawong
Journal of medical technology | 2016
Wanwisa Kaewkhankhaeng; Umaporn Yordpratum; Lumyai Wonglakorn; Suthida Kenprom; Aroonwadee Chanawong; Chotechana Wilailuckana; Nicha Charoensri
Journal of medical technology | 2014
Nicha Charoensri; Worrawalan Lerttam; Bundit Promraksa; Lumyai Wonglakorn; Suthida Kenprom; Porntip Pinlaor; Chotchana Wilailuckana
Journal of medical technology | 2012
Ratdawan Kanyota; Aroonlug Lulitanond; Aroonwadee Chanawong; Chotechana Wilailuckana; Chulapan Engchanil; Prajuab Chaimanee; Pirom Puang-Ngern; Amorn Auncharoen; Lumyai Wonglakorn